News

Varifarma at the European Congress of Hematology

June 12, 2022

Varifarma at the European Congress of Hematology

The hematology team travels to Vienna to participate in EHA.

SEE MORE

ASCO Annual Meeting 2022

June 2, 2022

ASCO Annual Meeting 2022

Varifarma participates together with Blanver and Stendhal

SEE MORE

Agreement with EUSA Pharma for Qarziba in Argentina.

April 7, 2022

Agreement with EUSA Pharma for Qarziba in Argentina.

Varifarma signs an exclusive distribution and licensing agreement for QARZIBA® in Argentina

SEE MORE

Blincyto®: Launch event in Chile

March 22, 2022

Blincyto®: Launch event in Chile

Update on the management of ALL presented by a board of international experts.

SEE MORE

Launching SUSTENGO®

November 29, 2021

Launching SUSTENGO®

Living with pulmonary arterial hypertension and QoL

SEE MORE

Launching UNITIOB®

August 5, 2021

Launching UNITIOB®

We announce the launch of UNITIOB® (sunitinib) to the medical community.

SEE MORE

Launching BLINCYTO® in Peru and Ecuador

May 7, 2021

Launching BLINCYTO® in Peru and Ecuador

Varifarma is proud to introduce BLINCYTO® (blinatumomab), an innovative therapy, in Peru and Ecuador.

SEE MORE

Agreement with Recordati for Ledaga® in Argentina

January 26, 2021

Agreement with Recordati for Ledaga® in Argentina

Varifarma signs an exclusive distribution and licensing agreement for LEDAGA® in Argentina

SEE MORE

Launching JANVAX®

January 20, 2021

Launching JANVAX®

SEE MORE

BINAP Bioequivalence Study

July 13, 2020

BINAP Bioequivalence Study

Varifarma is proud to present the BINAP Bioequivalence Study (Ibrutinib), which confirms its interchangeability with Imbruvica.

SEE MORE

Taking care of those who take care of us

May 11, 2020

Taking care of those who take care of us

During May and June, we donated protection supplies to over 90 hospitals in Argentina, Chile, Ecuador and Peru.

SEE MORE

Kyprolis: Launch event in Ecuador

March 5, 2020

Kyprolis: Launch event in Ecuador

On March 3 and 4, the launch events for Kyprolis® were held in the cities of Quito and Guayaquil, Ecuador.

SEE MORE

Varifarma celebrates the Annual Sales Convention

February 17, 2020

Varifarma celebrates the Annual Sales Convention

The Commercial department participated in the annual 3-day convention to be trained in different pathologies and therapies.

SEE MORE

Varifarma Peru and Myriad Genetics on a new agreement

February 14, 2020

Varifarma Peru and Myriad Genetics on a new agreement

Pleased to announce the new agreement of Varifarma Peru with Myriad Genetics for the quantity of its products in the country.

SEE MORE

San Antonio Breast Cancer Symposium

December 10, 2019

San Antonio Breast Cancer Symposium

Committed to the prevention, diagnosis and treatment of breast cancer, we attended San Antonio's Symposium.

SEE MORE

61st ASH annual meeting and exhibition

December 5, 2019

61st ASH annual meeting and exhibition

We spent a weekend at the annual meeting organized by the ASH to find the latest in hematology and oncohematology.

SEE MORE

Prolaris: New Test for Prostate Cancer

December 1, 2019

Prolaris: New Test for Prostate Cancer

Varifarma presents Prolaris, an innovative test for Prostate Cancer.

SEE MORE

Lenvatib: New Indication

November 7, 2019

Lenvatib: New Indication

Excited to announce a new indication: Lenvatib, approved under the ANMAT Approval Deposition: 7839/2019.

SEE MORE

Varifarma presents Idelib at the Argentine Oncology Congress

November 6, 2019

Varifarma presents Idelib at the Argentine Oncology Congress

Step by our booth Nº2 to find our latest news!

SEE MORE

World MDS Awareness Day

October 25, 2019

World MDS Awareness Day

By sharing knowledge and raising awareness of MDS diseases, we can help reduce stigma and foster a more informed and inclusive society.

SEE MORE

World Breast Cancer Awareness Day

October 19, 2019

World Breast Cancer Awareness Day

Varifarma and VSA joined the pink ribbon campaign to raise awareness about the importance of having routine breast checkups.

SEE MORE

October 15, 2019

FUCA's La Noche de Rosa

We attended FUCA's dinner for the benefit of their teaching and research programs.

SEE MORE

October 2, 2019

Varifarma attends the XXIV Argentina's Hematology Congress

We attended the 2019's Congress of Hematology in Argentina.

SEE MORE

September 27, 2019

ESMO Congress in Barcelona

Varifarma at the forefront in oncology.

SEE MORE

September 24, 2019

Varifarma at the Noche Azul

We participated in the annual dinner of GEDYT: Blue Night.

SEE MORE

September 22, 2019

World Leukemia day

We encourage to do the annual health checkups, in order to detect any sign and symptoms and find the adequate treatment.

SEE MORE

September 9, 2019

New Product: PONATIB®

New therapy announced.

SEE MORE

September 3, 2019

XIV Argentine and International Congress of Mastology

We attended for the first time ever, the Argentinian and International Congress of Mastology.

SEE MORE

September 2, 2019

Helsinn signs agreements with Blanver and Varifarma

Distribution and license agreements signed for Pracinostat in South America.

SEE MORE

August 30, 2019

Varifarma joins Fundaleu

We attended Fundaleu's 2019 night gala.

SEE MORE

August 20, 2019

Busulfan

Varifarma in transplant.

SEE MORE

August 10, 2019

Gammanorm® gives patients freedom

IgSC as Gammanorm® allows patients to be independent from hospital treatment.

SEE MORE

May 27, 2019

ASCO Annual Meeting

See you at #ASCO19 Annual Meeting!

SEE MORE

May 10, 2018

2018 ASCO - ANNUAL MEETING

This year, for the 13 th time in a row, we will be participating in the ASCO Annual Meeting.

SEE MORE

March 28, 2018

NEW RELEASE: GEFIT

Targeted therapy for locally advanced or metastatic non-small-cell lung cancer

SEE MORE

March 26, 2018

Emulimod

Prescribed for the treatment of patients suffering from recurrent (or relapsing) multiple sclerosis (MS).

SEE MORE

March 26, 2018

CABAZIL®

For the treatment of patients suffering from metastatic prostate cancer

SEE MORE

January 27, 2018

Presenting Dacarbazina

The only dacarbazine product available in the market.

SEE MORE

September 28, 2017

New Clinical Evidence

KYPROLIS ® Significantly improves overall survival in patients with relapsed multiple myeloma.

SEE MORE

July 26, 2017

Launches:

Amgen has entrusted us with the representation of two new licences: Neupogen (filgrastim) and Neulastim (pegfilgrastim).

SEE MORE

May 22, 2017

Launching Celixafor

We are pleassed to inform you about the incorporation of Celixafor®, Plerixafor 20 mg/ml 1 ampoule, to our hematology Vademecum.

SEE MORE

May 22, 2017

Invitation Stand ASCO 8112

Between the 2 to 6 of June, we will be part again of the world's biggest oncology congress: ASCO.

SEE MORE

February 20, 2017

Nuwiq

The First human recombinant factor VIII oh human cell

SEE MORE